Fused pyrazole derivatives being protein kinase inhibitors
US7166597B2 · kind B2 · utility
7Cited by
43References
13Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Aug 22, 2001 |
| Grant date | Jan 23, 2007 |
| Priority date | — |
| Expiry date | Jun 7, 2022 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P43/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Compounds of Formula (I): salts or solvates or physiologically functional derivatives thereof, wherein Z is CH or N, and R1, R2, and R4 are various substituent groups, are protein kinase inhibitors
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.